CAV1 and neoplasm: Univariate survival analysis of our series showed that those patients having caveolin-1-positive tumours had significantly worse prognosis with mean disease-free survival of 3.44 years compared to 6.20 years in those with negative caveolin-1 tumours (P=0.0005); a finding consistent with our previous investigation (Campbell et al, 2003).